Search
Login 800.380.7652 +1.408.717.4955 Blog Blog

ShareVault Business White Papers

White papers on business best practices and trends relevant to our customers, written by domain experts from a variety of fields

Understanding Recent Regulation A+ Changes Based on a Webinar of the Same Name, Featuring: Anna Pinedo, Partner, Morrison & Foerster LLP
Part 2: Must-Know Finance Concepts for Life Sciences Valuations Based on a Webinar of the Same Name, Featuring: John Selig, Co-Founder and Managing Partner, Mavericks Capital
The Nuts and Bolts of Due Diligence in Biopharma Partnering Linda Pullan, PhD, Pullan Consulting
James A. McCarthy, CLP, MBA, Corporate and Business Development, Alliance Management, CorpDev Ventures
Natalie Mirutenko, PhD, Transaction and Due Diligence Senior Director, The Center of External Innovation at Takeda
David L. Snitman, PhD, Partner, DL Snitman Inc
Patrick Gattari, JD, Partner, McDonnell Boehnen Hulbert and Berghoff
Ann-Marie Costelloe, AFBPS, Chartered Organization Psychologist, Executive Consultant, Somerville Partners
William Gangi, MS, MBA, Director, Due Diligence Program Manager - Corporate Development, Shire
Part 1: Must-Know Finance Concepts for Life Sciences Valuations Jeff Karan and John Selig, Co-Founders and Managing Partners, Mavericks Capital
What's Hot and What's Not in Immuno-Oncology Licensing Linda Pullan, PhD, Pullan Consulting
Jeff Bockman, PhD, Defined Health
Ferran Prat, PhD, MD Anderson
Axel Hoos, MD, PhD, GlaxoSmithKline
Nate Sanburn, MS, Lilly
Essential Steps to Successful BioPharma Partnering Gautam Aggarwal, Triangle Insights
M&A Negotiations: Are You As Good As You Could Be? by Brian Moriarty | Principal, Song Hill Capital and Former VP of Human Resources for Mergers, Acquisitions, Divestitures & Outsourcing (MADO), Hewlett-Packard
What's Hot & What's Not in Gene Therapies for Rare Disorders Based on a Web Panel of the Same Name, Featuring These Panelists:
Moderator: Michael C. Rice, MS, MBA, Senior Consultant, Defined Health
Matthew Porteus, MD, PhD, Associate Professor of Pediatrics (Cancer Biology), Stanford University
Paul Gallagher, MBA, President, Compass Strategic Consulting
Stewart Abbot, PhD, Former Executive Director, Integrative Research, Celgene Cellular Therapeutics (CCT), Currently VP of Translational Research, Fate Therapeutics
The Art & Science of High M&A Valuation David Stastny, Managing Director and Founder, Centaur Partners, LLC
Making Sense of New Patent Litigation Alternatives John Resek, PhD, JD, Co-Founder, Resek Liang & Frank LLC
What's Hot & What's Not in Oncology Licensing Linda Pullan, PhD Pullan Consulting
Jeff Bockman, PhD, Vice President, Defined Health
Paul Juniewicz, PhD, Vice President, Oncology Business Opportunities, Sanofi
Ferran Prat, PhD, VP of Strategic Industry Ventures, MD Anderson
The Seven Habits of Highly Effective Data Rooms
The Seller's Guide to M&A HR by Brian Moriarty, Principal, Song Hill Capital and Former VP of Human Resources for Mergers, Acquisitions, Divestitures & Outsourcing (MADO), Hewlett-Packard
The Seven Deadly Sins of M&A by David Stastny, Managing Director & Founder, Centaur Partners, LLC
Navigating Later-Stage Venture Financing Complexities by Tim Harris, Partner at Morrison & Foerster
How to Win at the Partnering Game by Linda M. Pullan, PhD, Pullan Consulting
Successful Biotech Licensing Negotiations by Linda M. Pullan, PhD, Pullan Consulting
How Equity Crowdfunding Can Help Life Science Companies by Scott Jordan, S Jordan Associates
Overcoming SharePoint Security Challenges by Don LaMure, SharePoint Silicon Valley User Group Founder
Valuation of Your Early Drug Candidate by Linda M. Pullan, PhD, Pullan Consulting
Building a Successful Business Development and Licensing Strategy by Carlos N. Velez PhD, MBA, Lacerta Bio
Building a Better Partnering Presentation by Linda M. Pullan, PhD, Pullan Consulting
Moving to the Cloud: Protecting Intellectual Property in the Borderless Enterprise by Richard Andersen, ShareVault
Preparing For Your Exit by Andy Thorson, Executive Vice President for Corporate Strategy and Business Development, Veracyte
Getting Ready for a Biopharma Partnering Deal by Linda M. Pullan, PhD, Pullan Consulting
7 Top M&A Deal Killers and How to Avoid Them by David Ron and Kevin Scott, Centaur Partners, LLC
Preparing Your Company for the M&A Process by Richard Andersen, CEO, ShareVault, Michael Bates, Former CFO, St. Francis Medical Technologies and Brian Moriarty, Former VP Business Affairs, Sun Microsystems